팍스로비드'의 긴급 사용을 승인했다. 미국 화이자의 먹는 코로나19(COVID-19) 치료제 '팍스로비드(성분명 니르마트렐비르[PF-07321332]/리토나비르)'가 최종 분석에서 상당한 치료 효과를 확인하며 팬데믹 판도를 바꿀 게임체인저로 떠올랐다. 21년 9월 미국 MSD(머크)사의 몰누피라비르 20만명분을 구매계약한
Background
Continue to threaten global health. (Covid-19)
Older age, current smoking, or underlying clinical conditions such as cardiovascular disease, diabetes, obesity, and cancer : high risk for severe Covid-19 and associated adverse outcomes.
Twice as likely to have progression to severe Covid-19 and five times as likely to die from Covid-19 as patients without those conditions.
A